Clinical Trial Update: Study, Double Blind, Randomized, Comparing Two Groups to Evaluate the Safety and Efficacy of Autologous Mesenchymal Stem Cells From Adipose Tissue (CMMAd) in the Treatment of the Faecal Incontinence [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the safety and potential efficacy of autologous adipose-derived mesenchymal stem cells (CMMAd) for treating fecal incontin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fecal Incontinence

Drugs mentioned

• CMMAd (Autologous adipose-derived mesenchymal stem cells)

Snippet

Sponsor: Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud | Conditions: Faecal Incontinence | Phase 1, Phase 2 | Status: COMPLETED